Annual Cash & Cash Equivalents
$14.49 M
-$541.00 K-3.60%
December 31, 2023
Summary
- As of February 7, 2025, PPBT annual cash & cash equivalents is $14.49 million, with the most recent change of -$541.00 thousand (-3.60%) on December 31, 2023.
- During the last 3 years, PPBT annual cash & cash equivalents has risen by +$3.24 million (+28.83%).
- PPBT annual cash & cash equivalents is now -88.10% below its all-time high of $121.76 million, reached on December 1, 2011.
Performance
PPBT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.44 M
-$1.09 M-16.65%
September 1, 2024
Summary
- As of February 7, 2025, PPBT quarterly cash and cash equivalents is $5.44 million, with the most recent change of -$1.09 million (-16.65%) on September 1, 2024.
- Over the past year, PPBT quarterly cash and cash equivalents has dropped by -$4.55 million (-45.54%).
- PPBT quarterly cash and cash equivalents is now -91.37% below its all-time high of $62.99 million, reached on June 30, 2020.
Performance
PPBT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PPBT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.6% | -45.5% |
| 3 y3 years | +28.8% | -50.9% |
| 5 y5 years | +180.6% | +24.0% |
PPBT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.6% | +33.0% | -76.9% | at low |
| 5 y | 5-year | -3.6% | +230.4% | -91.4% | +24.0% |
| alltime | all time | -88.1% | +7407.3% | -91.4% | +931.9% |
Purple Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.44 M(-16.6%) |
| Jun 2024 | - | $6.52 M(-34.7%) |
| Mar 2024 | - | $9.98 M(-31.1%) |
| Dec 2023 | $14.49 M(-3.6%) | $14.49 M(-4.1%) |
| Sep 2023 | - | $15.10 M(-12.2%) |
| Jun 2023 | - | $17.20 M(-21.4%) |
| Mar 2023 | - | $21.88 M(+45.6%) |
| Dec 2022 | $15.03 M(+38.0%) | $15.03 M(+35.7%) |
| Sep 2022 | - | $11.07 M(-20.9%) |
| Jun 2022 | - | $14.01 M(-40.5%) |
| Mar 2022 | - | $23.54 M(+116.1%) |
| Dec 2021 | $10.89 M(-3.2%) | $10.89 M(+19.4%) |
| Sep 2021 | - | $9.12 M(-13.5%) |
| Jun 2021 | - | $10.54 M(+3.4%) |
| Mar 2021 | - | $10.20 M(-9.4%) |
| Dec 2020 | $11.25 M(+156.5%) | $11.25 M(-82.1%) |
| Jun 2020 | - | $62.99 M(+1336.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $4.38 M(-15.1%) | $4.38 M(+59.0%) |
| Jun 2019 | - | $2.76 M(-46.6%) |
| Dec 2018 | $5.16 M(+30.8%) | $5.16 M(-3.7%) |
| Jun 2018 | - | $5.36 M(+35.9%) |
| Dec 2017 | $3.95 M(-41.6%) | $3.95 M(+649.0%) |
| Jun 2017 | - | $527.00 K(-92.2%) |
| Dec 2016 | $6.76 M(-36.0%) | $6.76 M(+71.8%) |
| Jun 2016 | - | $3.93 M(-62.7%) |
| Dec 2015 | $10.56 M(+704.1%) | $10.56 M(+976.2%) |
| Sep 2015 | - | $981.00 K(-40.6%) |
| Jun 2015 | - | $1.65 M(+25.8%) |
| Dec 2014 | $1.31 M(+580.3%) | $1.31 M |
| Dec 2013 | $193.00 K(-99.8%) | - |
| Dec 2012 | $102.76 M(-15.6%) | - |
| Dec 2011 | $121.76 M(+49.8%) | - |
| Dec 2010 | $81.26 M(-14.3%) | - |
| Dec 2009 | $94.81 M | - |
FAQ
- What is Purple Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Purple Biotech?
- What is Purple Biotech annual cash & cash equivalents year-on-year change?
- What is Purple Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Purple Biotech?
- What is Purple Biotech quarterly cash and cash equivalents year-on-year change?
What is Purple Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of PPBT is $14.49 M
What is the all time high annual cash & cash equivalents for Purple Biotech?
Purple Biotech all-time high annual cash & cash equivalents is $121.76 M
What is Purple Biotech annual cash & cash equivalents year-on-year change?
Over the past year, PPBT annual cash & cash equivalents has changed by -$541.00 K (-3.60%)
What is Purple Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PPBT is $5.44 M
What is the all time high quarterly cash and cash equivalents for Purple Biotech?
Purple Biotech all-time high quarterly cash and cash equivalents is $62.99 M
What is Purple Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, PPBT quarterly cash and cash equivalents has changed by -$4.55 M (-45.54%)